Pro Dex Inc
PDEX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000788920
In the last 90 days, Pro Dex Inc insiders filed 0 open-market purchases and 4 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $43.0M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Pro Dex Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 24 | 42 | +18 |
| Shares | 534.8K | 684.0K | +149.2K (+27.9%) |
| Value | $16.0M | $32.0M | +$16.0M (+100.3%) |
New holders (19)
Institutions that held Pro Dex Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| EAM Investors, LLC | 22,399 | $1.05M | 0.15% |
| O'Shaughnessy Asset Management, LLC | 21,277 | $994.7K | 0.01% |
| 683 Capital Management, LLC | 15,798 | $738.6K | 0.07% |
| Ritholtz Wealth Management | 12,233 | $571.9K | 0.02% |
| American Century Companies Inc | 11,946 | $558.5K | 0.00% |
| Marshall Wace, LLP | 9,260 | $432.9K | 0.00% |
| Goldman Sachs Group Inc | 7,198 | $336.5K | 0.00% |
| Russell Investments Group, Ltd. | 6,999 | $327.2K | 0.00% |
| Omers Administration Corp | 6,700 | $313.2K | 0.00% |
| Susquehanna International Group, LLP | 6,438 | $301.0K | 0.00% |
| Millennium Management LLC | 5,568 | $260.3K | 0.00% |
| Arrowstreet Capital, Limited Partnership | 5,448 | $254.7K | 0.00% |
| Integrated Quantitative Investments LLC | 5,432 | $253.9K | 0.13% |
| Trexquant Investment LP | 5,387 | $251.8K | 0.00% |
| Bank of New York Mellon Corp | 4,319 | $201.9K | 0.00% |
| Citigroup Inc | 3,201 | $149.6K | 0.00% |
| Lazard Asset Management LLC | 152 | $7.00K | 0.00% |
| Farther Finance Advisors, LLC | 61 | $2.85K | 0.00% |
| Hurley Capital, LLC | 60 | $2.82K | 0.00% |
Sold out (1)
Institutions that held Pro Dex Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Barclays PLC | 148 | $4.42K |